Progress in medical treatment is only made possible with the help of volunteers who give their time to participate in trials. The Australian Dementia Network (ADNeT) has set up a Volunteer Register (or Volunteer Portal) for persons who would like to participate in research into the causes, prevention, and treatment of dementia.

If you are aged 50 years or older and are considering volunteering, please first take a moment to look at the Participant Information Sheet / Consent Form (PICF) below. You can also download a copy of this document by clicking on the link provided.

If, after reading the PICF, you would like to volunteer, please tick the box at the bottom of this page to confirm you have read and understood the information provide and then click on the Go to the Questionnaire button.

On the next page, you will be asked to complete a short questionnaire. Your answers to these questions help us refer to you to a trial. After you complete the questionnaire, your volunteer registration is complete. We will contact you if we find a trial to which you might be suitable. If later you would like to remove yourself from our contact list or alter the information you have provided us, just send an email with your request to adnet-screening@unimelb.edu.au.

Download the Participant Information Sheet and Consent Form (PICF)

Please take a moment to look at the information and questions further down this page.

If you wish to proceed to become a volunteer with us, please:

• enter your contact details in Part 1. Contact Details,
• answer all 14 questions in Part 2. Questionnaire,
• select the type of trials you would like to participate in Part 3. Trials, and
• click the Sign Up button.

If you would later like to remove yourself from our contact list or alter the information you have provided, please just email your request to  adnet-trials@unimelb.edu.au

Part 2. ADNeT Questionnaire

Please complete all questions

13. Have you had any of the following:

14. Do you have any of the following that make it unsafe to have an MRI scan:

Part 3. Trials